Market Momentum Shifts as Top Funds Rally
After months of volatility, China’s equity markets are flashing green with conviction. The Shanghai Composite Index’s surge past 3700 points signals more than a temporary rebound—it heralds what institutions now identify as the early stage of a sustainable slow bull market. At the forefront are China’s elite “billion-level” active equity funds (funds exceeding ¥10 billion AUM), with standouts like Peng Hua Carbon Neutrality Theme A delivering 73.46% year-to-date returns through mid-August 2025. This resurgence stems from strategic pivots toward healthcare and tech sectors before their explosive growth, combined with improving macroeconomic tailwinds. As capital floods back into equities via margin trading, institutional investors, and foreign inflows, the stage is set for a fundamentally driven ascent.
Top Performing Funds and Their Winning Strategies
Returns Breakdown and Sector Allocation
Among the 22 billion-level active equity funds tracked, over 80% generated positive returns by mid-August 2025. Leading performers shared a common thread: early bets on innovation-driven sectors: – Peng Hua Carbon Neutrality Theme A: 73.46% YTD – Heavy exposure to humanoid robotics and advanced manufacturing – Yongying Advanced Manufacturing Intelligent Selection A: 65.27% YTD – Focused on automation and industrial upgrades – ICBC Frontier Medical A (managed by Zhao Bei 赵蓓): 30%+ YTD – Overweight in innovative drugmakers benefiting from license-out deals – Ruifuan Growth Value A (managed by Fu Pengbo 傅鹏博 and Zhu Lin 朱璘): 30%+ YTD – Positions in electronics, precision manufacturing, and biotech These funds capitalized on two transformative trends: China’s push for technological self-reliance and healthcare reform. ICBC Frontier Medical’s Q2 report highlighted how domestic innovators like BeiGene (百济神州) now rival global pharma in R&D capabilities—evidenced by record licensing deals with Western firms. Similarly, Ruifuan Growth Value credited PCB manufacturers and Hong Kong tech stocks for portfolio gains.
Manager Insights on Positioning
Portfolio disclosures reveal tactical adjustments anticipating policy shifts: – China Europe Medical Health A (managed by Ge Lan 葛兰 and Zhao Lei 赵磊) doubled down on oncology and rare-disease therapies before regulatory reforms – GF Multi-Factor (managed by Tang Xiaobin 唐晓斌 and Yang Dong 杨冬) rotated into financials and utilities as defensive plays – China Europe Times Pioneer A (managed by Zhou Weiwen 周蔚文 and Luo Jiaming 罗佳明) increased AI infrastructure holdings by 40% in Q2 Zhou Weiwen noted: “We’re witnessing a supply-side revolution in biotech and automation. Leaders with robust pipelines will dominate post-consolidation markets.”
Drivers Behind the Sustainable Slow Bull Thesis
Capital Flow Dynamics
Yongying Fund analysts pinpoint three reinforcing capital drivers: 1. Policy catalysts like the “anti-internal competition” reforms reducing market fragmentation 2. High-risk capital re-entry via margin trading (up 12% monthly since July 2025) 3. Institutional buying from mutual funds, insurers, and foreign investors (>¥80 billion net inflows) This creates what Peng Hua’s research head Zhang Junxiao calls a “virtuous liquidity cycle”—where price gains attract fresh capital, further fueling advances without bubble formation. Supporting this, the Buffett Indicator (market cap/GDP) remains at 85%, below historical danger zones.
Structural Economic Shifts
While July’s PMI dip revealed persistent demand weakness, institutions see counterbalancing forces enabling the sustainable slow bull scenario: – Industrial upgrade acceleration: Robotics and AI adoption rising 25% annually – Fiscal stimulus: Special bond issuance accelerated by State Council directive – Corporate reform: SOE efficiency targets lifting ROE in traditional sectors Zhang Junxiao emphasizes: “Dual engines of new productive forces (AI, green tech) and traditional industry transformation will reshape China’s valuation paradigm sustainably.”
Investor Strategies for the Emerging Slow Bull
Portfolio Construction Principles
Xingquan Global Fund recommends three defensive approaches: – Systematic allocation reviews: Balance real estate, fixed income, and equity exposure quarterly – Avoid chasing momentum: Scale into positions via dollar-cost averaging – Hold quality through volatility: “Don’t uproot flowers to water weeds” by selling winners prematurely Historical data shows investors who held top 20% performing funds for 3+ years outperformed market timers by 9% annually.
Sector Opportunities and Risks
Fund managers prioritize two clusters with sustainable slow bull potential: High-Conviction Sectors: – Biotech: Innovation drugmakers with global partnerships (e.g., Innovent Bio 信达生物) – Industrial Automation: Robotics supply chain leaders – AI Infrastructure: Data center and semiconductor equipment makers Caution Areas: – Consumer discretionary: Weak household spending persists – Commodity cyclicals: Oversupply in steel/cement may pressure margins Zhong Ou Fund’s Luo Jiaming advises: “Stick within your circle of competence. If sector-picking proves difficult, consider broad-based index trackers like CSI 300 ETFs.”
Forward Outlook: Sustaining the Bull Run
The convergence of policy support, industrial innovation, and earnings recovery creates conditions for prolonged market health. Key watchpoints: – Infrastructure stimulus impact: Regional project commencements (targeting 8% Q3 growth) – Corporate profit revisions: Q2 earnings beat estimates by 4% overall – Global capital rotation: MSCI China weighting increases attracting $17 billion passive flows Crucially, this sustainable slow bull differs from past rallies. As Yongying Fund notes: “Unlike 2020’s liquidity surge, this phase combines moderate valuations with tangible productivity gains.” Investors should position for 18-24 month horizons, leveraging sector ETFs or actively managed funds with consistent 5-year records. Monitor quarterly fund disclosures for allocation clues—particularly toward National Team policy beneficiaries. The window for strategic entry remains open, but discipline will determine who profits from China’s next market chapter.